Test-retest reproducibility of extrastriatal binding with 123I-FP-CIT SPECT in healthy male subjects

123I-labeled 2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane (123I-FP-CIT) is used to assess striatal dopamine transporter (DAT) expression, but it can also quantify extrastriatal serotonin transporter (SERT) expressions. While FP-CIT uptake in extrastriatal regions has been quantifi...

Full description

Saved in:
Bibliographic Details
Published inPsychiatry research. Neuroimaging Vol. 258; pp. 10 - 15
Main Authors Matsuoka, Kiwamu, Yasuno, Fumihiko, Shinkai, Takayuki, Miyasaka, Toshiteru, Takahashi, Masato, Kiuchi, Kuniaki, Kosaka, Jun, Inoue, Makoto, Kichikawa, Kimihiko, Hasegawa, Masatoshi, Kishimoto, Toshifumi
Format Journal Article
LanguageEnglish
Published Elsevier Ireland Ltd 30.12.2016
Subjects
Online AccessGet full text
ISSN0925-4927
1872-7506
DOI10.1016/j.pscychresns.2016.10.007

Cover

More Information
Summary:123I-labeled 2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane (123I-FP-CIT) is used to assess striatal dopamine transporter (DAT) expression, but it can also quantify extrastriatal serotonin transporter (SERT) expressions. While FP-CIT uptake in extrastriatal regions has been quantified, no information exists on the reproducibility of the 123I-FP-CIT specific uptake ratio (SUR) in extrastriatal regions. We investigated test-retest reproducibility of 123I-FP-CIT binding in the striatum, the midbrain, and cortical regions in eight healthy male subjects. All subjects underwent two 123I-FP-CIT SPECT scans, and SUR was calculated using the cerebellum as the reference. We found good test-retest reproducibility of 123I-FP-CIT SUR in the midbrain, and in the lateral frontal/temporal cortex and combined cortical regions. The overall variability and intraclass correlation of SUR were, respectively, 4.9–7.8% and 0.90–0.96 in striatal regions, 8.6% and 0.79 in the midbrain, and 3.6–9.1% and 0.84–0.95 in the lateral frontal/temporal cortex and combined cortical regions. Our results provide evidence that 123I-FP-CIT SPECT is a valid technique for analyzing striatal DAT, as well as extrastriatal SERT in areas such as the SERT-enriched midbrain. In addition, our data suggest that 123I-FP-CIT could be used for analyzing SERT in regions with relatively low SERT expression (e.g., temporal or frontal cortices). •Reproducibility of 123I-FP-CIT binding in extrastriatal regions was examined.•Specific uptake ratio (SUR) was calculated using the cerebellum as the reference.•Good reproducibility of 123I-FP-CIT SUR was found in extrastriatal regions.•123I-FP-CIT SPECT is a valid technique for analyzing extrastriatal regions.•123I-FP-CIT SPECT can be used for analyzing striatal DAT and extrastriatal SERT.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0925-4927
1872-7506
DOI:10.1016/j.pscychresns.2016.10.007